| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anti-Bacterial Agents | 16 | 2018 | 138 | 3.910 |
Why?
|
| Drug Utilization | 16 | 2018 | 134 | 2.460 |
Why?
|
| Asthma | 23 | 2010 | 302 | 2.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2018 | 393 | 1.910 |
Why?
|
| Parents | 11 | 2018 | 308 | 1.780 |
Why?
|
| Practice Patterns, Physicians' | 14 | 2018 | 351 | 1.730 |
Why?
|
| Child, Preschool | 38 | 2018 | 1428 | 1.510 |
Why?
|
| Child | 46 | 2018 | 2519 | 1.410 |
Why?
|
| Respiratory Tract Infections | 5 | 2016 | 53 | 1.290 |
Why?
|
| Chronic Disease | 7 | 2018 | 462 | 1.150 |
Why?
|
| Adolescent | 32 | 2018 | 3714 | 1.000 |
Why?
|
| Infant | 16 | 2018 | 1212 | 1.000 |
Why?
|
| Medicaid | 13 | 2018 | 206 | 0.920 |
Why?
|
| Male | 42 | 2018 | 10173 | 0.910 |
Why?
|
| Health Education | 5 | 2008 | 118 | 0.840 |
Why?
|
| Female | 43 | 2018 | 12838 | 0.820 |
Why?
|
| Massachusetts | 12 | 2017 | 100 | 0.800 |
Why?
|
| Humans | 52 | 2018 | 18058 | 0.790 |
Why?
|
| Pneumococcal Infections | 3 | 2011 | 54 | 0.770 |
Why?
|
| Anti-Asthmatic Agents | 8 | 2005 | 67 | 0.770 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2012 | 70 | 0.730 |
Why?
|
| Attitude of Health Personnel | 4 | 2018 | 227 | 0.700 |
Why?
|
| Quality of Health Care | 4 | 2018 | 346 | 0.680 |
Why?
|
| United States | 26 | 2018 | 4119 | 0.670 |
Why?
|
| Physicians | 2 | 2018 | 143 | 0.650 |
Why?
|
| Managed Care Programs | 13 | 2008 | 356 | 0.610 |
Why?
|
| Crohn Disease | 2 | 2007 | 16 | 0.610 |
Why?
|
| Inappropriate Prescribing | 2 | 2016 | 9 | 0.610 |
Why?
|
| Transition to Adult Care | 1 | 2017 | 11 | 0.600 |
Why?
|
| Medication Reconciliation | 1 | 2017 | 5 | 0.600 |
Why?
|
| Pediatric Obesity | 1 | 2018 | 75 | 0.590 |
Why?
|
| Emergency Service, Hospital | 3 | 2018 | 357 | 0.560 |
Why?
|
| Critical Care | 1 | 2017 | 72 | 0.560 |
Why?
|
| Patient Readmission | 1 | 2018 | 161 | 0.540 |
Why?
|
| Ambulatory Care | 3 | 2016 | 274 | 0.540 |
Why?
|
| Insurance, Health | 4 | 2014 | 221 | 0.530 |
Why?
|
| Primary Health Care | 6 | 2010 | 843 | 0.510 |
Why?
|
| Multivariate Analysis | 8 | 2017 | 595 | 0.480 |
Why?
|
| Infant, Newborn | 6 | 2018 | 852 | 0.480 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2013 | 13 | 0.470 |
Why?
|
| Pneumococcal Vaccines | 3 | 2009 | 80 | 0.440 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 29 | 0.420 |
Why?
|
| Streptococcus pneumoniae | 1 | 2011 | 25 | 0.400 |
Why?
|
| Adult | 13 | 2018 | 7696 | 0.400 |
Why?
|
| Models, Economic | 1 | 2011 | 21 | 0.390 |
Why?
|
| Health Care Surveys | 6 | 2017 | 252 | 0.370 |
Why?
|
| Health Services Accessibility | 4 | 2010 | 316 | 0.360 |
Why?
|
| Pediatrics | 6 | 2014 | 164 | 0.360 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2009 | 6 | 0.350 |
Why?
|
| Carrier State | 1 | 2009 | 7 | 0.350 |
Why?
|
| Staphylococcal Infections | 1 | 2009 | 14 | 0.350 |
Why?
|
| Medication Adherence | 1 | 2012 | 255 | 0.340 |
Why?
|
| Delivery of Health Care | 2 | 2011 | 445 | 0.330 |
Why?
|
| Drug Resistance, Microbial | 1 | 2008 | 4 | 0.320 |
Why?
|
| Cross-Sectional Studies | 7 | 2018 | 1309 | 0.310 |
Why?
|
| Colitis, Ulcerative | 1 | 2007 | 10 | 0.310 |
Why?
|
| Logistic Models | 6 | 2010 | 953 | 0.310 |
Why?
|
| Pharyngitis | 2 | 2016 | 11 | 0.300 |
Why?
|
| Prospective Studies | 5 | 2017 | 1294 | 0.300 |
Why?
|
| Gastrointestinal Agents | 1 | 2007 | 4 | 0.300 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2004 | 25 | 0.290 |
Why?
|
| Otitis Media | 3 | 2012 | 21 | 0.280 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 215 | 0.280 |
Why?
|
| Hospital Charges | 1 | 2006 | 8 | 0.270 |
Why?
|
| Streptococcus pyogenes | 1 | 2005 | 6 | 0.270 |
Why?
|
| Focus Groups | 2 | 2018 | 152 | 0.270 |
Why?
|
| Young Adult | 4 | 2018 | 2479 | 0.270 |
Why?
|
| Streptococcal Infections | 1 | 2005 | 21 | 0.270 |
Why?
|
| Outcome and Process Assessment (Health Care) | 2 | 2004 | 106 | 0.260 |
Why?
|
| Quality Assurance, Health Care | 2 | 2008 | 188 | 0.260 |
Why?
|
| Hospitalization | 5 | 2007 | 813 | 0.260 |
Why?
|
| Drug Prescriptions | 4 | 2008 | 157 | 0.250 |
Why?
|
| Macrolides | 1 | 2004 | 7 | 0.250 |
Why?
|
| Cluster Analysis | 4 | 2009 | 97 | 0.250 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2005 | 248 | 0.240 |
Why?
|
| Middle Aged | 8 | 2018 | 8073 | 0.240 |
Why?
|
| Otitis | 1 | 2003 | 1 | 0.230 |
Why?
|
| Data Collection | 3 | 2014 | 276 | 0.220 |
Why?
|
| Severity of Illness Index | 5 | 2010 | 454 | 0.220 |
Why?
|
| Total Quality Management | 1 | 2002 | 30 | 0.210 |
Why?
|
| Air Pollution, Indoor | 1 | 2002 | 7 | 0.210 |
Why?
|
| Retrospective Studies | 6 | 2018 | 2498 | 0.210 |
Why?
|
| Attitude to Health | 1 | 2003 | 179 | 0.210 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 80 | 0.200 |
Why?
|
| Environmental Exposure | 1 | 2002 | 108 | 0.200 |
Why?
|
| Risk Factors | 5 | 2011 | 3394 | 0.190 |
Why?
|
| Incidence | 4 | 2011 | 1297 | 0.190 |
Why?
|
| Age Distribution | 3 | 2018 | 257 | 0.180 |
Why?
|
| Interviews as Topic | 2 | 2018 | 327 | 0.170 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 35 | 0.160 |
Why?
|
| Prevalence | 3 | 2016 | 892 | 0.160 |
Why?
|
| Hospitals, High-Volume | 1 | 2018 | 2 | 0.160 |
Why?
|
| Maryland | 1 | 2018 | 15 | 0.160 |
Why?
|
| New York | 1 | 2018 | 21 | 0.160 |
Why?
|
| Risk | 2 | 2018 | 552 | 0.160 |
Why?
|
| Risk Assessment | 4 | 2008 | 1137 | 0.160 |
Why?
|
| Confidence Intervals | 4 | 2008 | 249 | 0.150 |
Why?
|
| Family Practice | 3 | 2008 | 58 | 0.150 |
Why?
|
| Urban Population | 1 | 2018 | 122 | 0.150 |
Why?
|
| Near Miss, Healthcare | 1 | 2017 | 1 | 0.150 |
Why?
|
| Medication Errors | 1 | 2017 | 9 | 0.150 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 15 | 0.150 |
Why?
|
| Otitis Media, Suppurative | 1 | 2016 | 1 | 0.140 |
Why?
|
| Odds Ratio | 4 | 2008 | 692 | 0.140 |
Why?
|
| Time Factors | 2 | 2018 | 1114 | 0.140 |
Why?
|
| Models, Statistical | 1 | 2017 | 184 | 0.130 |
Why?
|
| Overweight | 1 | 2018 | 272 | 0.130 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 228 | 0.130 |
Why?
|
| Health Services | 2 | 2007 | 111 | 0.130 |
Why?
|
| Cohort Studies | 8 | 2018 | 2631 | 0.130 |
Why?
|
| Education, Medical, Continuing | 2 | 2005 | 31 | 0.130 |
Why?
|
| Age Factors | 3 | 2008 | 945 | 0.120 |
Why?
|
| Computer Communication Networks | 1 | 2014 | 18 | 0.120 |
Why?
|
| Midwestern United States | 1 | 2014 | 4 | 0.120 |
Why?
|
| New England | 1 | 2014 | 13 | 0.120 |
Why?
|
| Northwestern United States | 1 | 2014 | 47 | 0.120 |
Why?
|
| Medicine, Traditional | 1 | 2013 | 4 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2005 | 60 | 0.120 |
Why?
|
| Watchful Waiting | 1 | 2013 | 18 | 0.120 |
Why?
|
| Aged | 4 | 2016 | 6258 | 0.110 |
Why?
|
| Influenza Vaccines | 2 | 2006 | 284 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2012 | 10 | 0.110 |
Why?
|
| Educational Status | 2 | 2003 | 205 | 0.110 |
Why?
|
| Continental Population Groups | 2 | 2006 | 317 | 0.100 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 2 | 2009 | 22 | 0.100 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 202 | 0.100 |
Why?
|
| Socioeconomic Factors | 3 | 2010 | 667 | 0.100 |
Why?
|
| Office Visits | 3 | 2008 | 85 | 0.100 |
Why?
|
| Sinusitis | 1 | 2011 | 14 | 0.100 |
Why?
|
| Probability | 2 | 2008 | 86 | 0.100 |
Why?
|
| Group Practice | 2 | 2008 | 25 | 0.090 |
Why?
|
| Inpatients | 1 | 2011 | 79 | 0.090 |
Why?
|
| Outpatients | 1 | 2011 | 113 | 0.090 |
Why?
|
| Sepsis | 1 | 2011 | 71 | 0.090 |
Why?
|
| Nasal Cavity | 1 | 2009 | 2 | 0.090 |
Why?
|
| Regression Analysis | 2 | 2007 | 319 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 1255 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2011 | 253 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2010 | 136 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 233 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2014 | 734 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 33 | 0.080 |
Why?
|
| Amoxicillin | 1 | 2008 | 3 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2008 | 36 | 0.080 |
Why?
|
| Reference Values | 1 | 2008 | 86 | 0.080 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 92 | 0.080 |
Why?
|
| Mesalamine | 1 | 2007 | 1 | 0.080 |
Why?
|
| Prednisolone | 1 | 2007 | 3 | 0.080 |
Why?
|
| Infliximab | 1 | 2007 | 7 | 0.080 |
Why?
|
| Canada | 1 | 2007 | 66 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 20 | 0.080 |
Why?
|
| Health Maintenance Organizations | 3 | 2006 | 481 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2007 | 27 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2008 | 267 | 0.070 |
Why?
|
| Teratogens | 1 | 2006 | 5 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2006 | 324 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2008 | 350 | 0.070 |
Why?
|
| Drug Therapy | 1 | 2006 | 24 | 0.070 |
Why?
|
| Mass Media | 1 | 2006 | 18 | 0.070 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 17 | 0.070 |
Why?
|
| Sex Factors | 1 | 2008 | 634 | 0.070 |
Why?
|
| Influenza, Human | 2 | 2006 | 277 | 0.070 |
Why?
|
| Peer Group | 1 | 2005 | 50 | 0.070 |
Why?
|
| Policy Making | 1 | 2005 | 18 | 0.070 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2005 | 4 | 0.070 |
Why?
|
| Surveys and Questionnaires | 3 | 2006 | 1346 | 0.060 |
Why?
|
| Registries | 1 | 2007 | 486 | 0.060 |
Why?
|
| Health Surveys | 1 | 2005 | 266 | 0.060 |
Why?
|
| Physicians, Family | 1 | 2004 | 48 | 0.060 |
Why?
|
| Cultural Diversity | 1 | 2004 | 17 | 0.060 |
Why?
|
| Vaccines, Conjugate | 1 | 2004 | 66 | 0.060 |
Why?
|
| Immunization Programs | 1 | 2004 | 68 | 0.060 |
Why?
|
| Vaccination | 2 | 2006 | 664 | 0.060 |
Why?
|
| Meningococcal Vaccines | 1 | 2004 | 46 | 0.060 |
Why?
|
| Process Assessment (Health Care) | 1 | 2003 | 27 | 0.060 |
Why?
|
| Research Design | 2 | 2004 | 393 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2003 | 162 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2004 | 160 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2003 | 97 | 0.050 |
Why?
|
| Linear Models | 1 | 2003 | 240 | 0.050 |
Why?
|
| Chicago | 1 | 2002 | 27 | 0.050 |
Why?
|
| Ethnic Groups | 2 | 2006 | 504 | 0.050 |
Why?
|
| Boston | 1 | 2002 | 37 | 0.050 |
Why?
|
| Efficiency, Organizational | 1 | 2002 | 37 | 0.050 |
Why?
|
| Case Management | 1 | 2002 | 37 | 0.050 |
Why?
|
| Minority Groups | 1 | 2002 | 103 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 318 | 0.050 |
Why?
|
| Washington | 1 | 2002 | 384 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2002 | 236 | 0.050 |
Why?
|
| Pregnancy | 1 | 2006 | 1484 | 0.050 |
Why?
|
| Child Health Services | 1 | 2002 | 128 | 0.050 |
Why?
|
| Community Health Centers | 1 | 2002 | 109 | 0.050 |
Why?
|
| Patient Selection | 1 | 2002 | 194 | 0.050 |
Why?
|
| Health Behavior | 1 | 2003 | 379 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2003 | 303 | 0.050 |
Why?
|
| Mass Screening | 1 | 2006 | 678 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 742 | 0.040 |
Why?
|
| Body Height | 1 | 2018 | 59 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2008 | 1259 | 0.040 |
Why?
|
| Body Weight | 1 | 2018 | 216 | 0.040 |
Why?
|
| Steroids | 2 | 2007 | 15 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2007 | 81 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 705 | 0.030 |
Why?
|
| Vocabulary, Controlled | 1 | 2014 | 1 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2014 | 43 | 0.030 |
Why?
|
| State Health Plans | 2 | 2004 | 43 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2014 | 55 | 0.030 |
Why?
|
| Administration, Inhalation | 2 | 2004 | 31 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2018 | 961 | 0.030 |
Why?
|
| Poverty | 2 | 2003 | 177 | 0.030 |
Why?
|
| Reimbursement Mechanisms | 1 | 2008 | 20 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 97 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 129 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2008 | 192 | 0.020 |
Why?
|
| Acute Disease | 1 | 2008 | 138 | 0.020 |
Why?
|
| Recurrence | 1 | 2008 | 186 | 0.020 |
Why?
|
| Health Services Administration | 1 | 2007 | 6 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2007 | 46 | 0.020 |
Why?
|
| Health Policy | 1 | 2008 | 135 | 0.020 |
Why?
|
| Caregivers | 1 | 2007 | 125 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 106 | 0.020 |
Why?
|
| Korea | 1 | 2005 | 9 | 0.020 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2005 | 20 | 0.020 |
Why?
|
| Child Welfare | 1 | 2004 | 40 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2004 | 92 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2004 | 66 | 0.020 |
Why?
|
| Utilization Review | 1 | 2004 | 54 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2004 | 26 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 264 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 160 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2006 | 344 | 0.010 |
Why?
|
| Vulnerable Populations | 1 | 2003 | 45 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2004 | 109 | 0.010 |
Why?
|
| Health Services Research | 1 | 2004 | 271 | 0.010 |
Why?
|
| Disease Management | 1 | 2003 | 143 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2002 | 15 | 0.010 |
Why?
|
| Private Practice | 1 | 2002 | 15 | 0.010 |
Why?
|
| Fee-for-Service Plans | 1 | 2002 | 28 | 0.010 |
Why?
|
| Communication | 1 | 2003 | 205 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2002 | 197 | 0.010 |
Why?
|
| Health Status | 1 | 2002 | 331 | 0.010 |
Why?
|
| Hispanic Americans | 1 | 2002 | 431 | 0.010 |
Why?
|
| European Continental Ancestry Group | 1 | 2002 | 559 | 0.010 |
Why?
|
| African Americans | 1 | 2002 | 485 | 0.010 |
Why?
|